Featured Research

from universities, journals, and other organizations

Renegades of cell biology: Why K-Ras gene mutations prove so deadly in cancer

Date:
December 19, 2013
Source:
University of Utah Health Sciences
Summary:
Cells with a mutation in the gene called K-Ras —- found in close to 30 percent of all cancers, but mostly those with worst prognosis, such as pancreatic cancer, colon cancer, and lung cancer -— subvert the normal mechanisms of cell death.

“Epithelia act as a skin that coat and protect most organs and are the sites where most solid tumors arise. When cells become too crowded (due to cells dividing), some cells pop out and die. The surprising thing we found in this study is that cells with the K-Ras mutations pop into the tissue and instead live,” said Jody Rosenblatt, PhD.
Credit: University of Utah Health Sciences

Cells with a mutation in the gene called K-Ras—found in close to 30 percent of all cancers, but mostly those with worst prognosis, such as pancreatic cancer, colon cancer, and lung cancer—behave in ways that subvert the normal mechanisms of cell death, according to a cell-culture study by researchers from Huntsman Cancer Institute (HCI) at the University of Utah.

Normal cells need survival signals from the tissue that surrounds them to remain alive. Other research has shown cells with the K-Ras mutation can survive and direct their own fate without these signals.

“Epithelia act as a skin that coat and protect most organs and are the sites where most solid tumors arise. Our previous studies showed that cells making up epithelia turnover at high rates due to mechanical pressure. When cells become too crowded (due to cells dividing), some cells pop out and die. The surprising thing we found in this study is that cells with the K-Ras mutations pop into the tissue and instead live,” said Jody Rosenblatt, PhD, an HCI investigator and associate professor in the Department of Oncological Sciences at the University of Utah who co-authored the study.

Related Articles


The process of popping cells from epithelia is called extrusion, and in normal cells, this leads to cell death to keep the number of cells under control. “Our new study suggests that this oncogene subverts the mechanism of normal cell death to promote invasion.”

Another characteristic of cells with K-Ras mutations is that they consume parts of themselves (a process called autophagy) to keep up with the energy demands of rapid and unchecked cell division that the mutation causes.

“In normal cells that are about to extrude out, large quantities of an important signal called Sphingosine1-Phosphate (S1P) are present. Cells with the K-Ras mutation also produce S1P, but digest it through autophagy, so it cannot do its job and the cells extrude into the tissue,” said Gloria Slattum, doctoral candidate in the Rosenblatt Lab and lead author of the article. “When we blocked autophagy using a common anti-malaria drug called Chloroquine, the cells with K-Ras mutations extruded out of the tissue and died, just as normal cells do.”

The results were published online December 19 in the journal Current Biology


Story Source:

The above story is based on materials provided by University of Utah Health Sciences. Note: Materials may be edited for content and length.


Journal Reference:

  1. Gloria Slattum, Yapeng Gu, Roger Sabbadini, Jody Rosenblatt. Autophagy in Oncogenic K-Ras Promotes Basal Extrusion of Epithelial Cells by Degrading S1P. Current Biology, 2013; DOI: 10.1016/j.cub.2013.11.029

Cite This Page:

University of Utah Health Sciences. "Renegades of cell biology: Why K-Ras gene mutations prove so deadly in cancer." ScienceDaily. ScienceDaily, 19 December 2013. <www.sciencedaily.com/releases/2013/12/131219125955.htm>.
University of Utah Health Sciences. (2013, December 19). Renegades of cell biology: Why K-Ras gene mutations prove so deadly in cancer. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2013/12/131219125955.htm
University of Utah Health Sciences. "Renegades of cell biology: Why K-Ras gene mutations prove so deadly in cancer." ScienceDaily. www.sciencedaily.com/releases/2013/12/131219125955.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins